Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease.

Krivak TC, Rose GS, McBroom JW, Carlson JW, Winter WE 3rd, Kost ER.

Obstet Gynecol Surv. 2001 Sep;56(9):567-75. Review.

PMID:
11524622
2.

Is conservative treatment for adenocarcinoma in situ of the cervix safe?

Soutter WP, Haidopoulos D, Gornall RJ, McIndoe GA, Fox J, Mason WP, Flanagan A, Nicholas N, Barker F, Abrahams J, Lampert I, Sarhanis P.

BJOG. 2001 Nov;108(11):1184-9.

3.

Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.

Srisomboon J, Kietpeerakool C, Suprasert P, Siriaunkgul S, Khunamornpong S, Prompittayarat W.

Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):225-8.

4.

Conservative management of adenocarcinoma in situ of the cervix.

Shin CH, Schorge JO, Lee KR, Sheets EE.

Gynecol Oncol. 2000 Oct;79(1):6-10.

PMID:
11006022
5.

Adenocarcinoma in situ of the cervix: management and outcome.

Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT.

Gynecol Oncol. 1999 Jun;73(3):348-53.

PMID:
10366458
6.

Management of cervical premalignant lesions.

Lindeque BG.

Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):545-61. Epub 2005 Mar 26. Review.

PMID:
16150393
7.

Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.

Cohn DE, Morrison CD, Zanagnolo VL, Goist MM, Copeland LJ.

Gynecol Oncol. 2005 Jul;98(1):158-60.

PMID:
15913738
8.

Adenocarcinoma in situ of the uterine cervix--a systematic review.

Baalbergen A, Helmerhorst TJ.

Int J Gynecol Cancer. 2014 Nov;24(9):1543-8. doi: 10.1097/IGC.0000000000000260. Review.

PMID:
25238167
9.

Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.

Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF.

Obstet Gynecol. 1996 Jul;88(1):82-6.

PMID:
8684768
10.

[Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature].

Omnes S, Morice P, Camatte S, Rouzier R, Pautier P, Pomel C, Lhommé C, Haie-Meder C, Duvillard P, Castaigne D.

Gynecol Obstet Fertil. 2003 Nov;31(11):912-9. French.

PMID:
14623554
11.

Cervical adenocarcinoma in situ.

Hopkins MP, Roberts JA, Schmidt RW.

Obstet Gynecol. 1988 Jun;71(6 Pt 1):842-4. Review.

PMID:
3285263
12.

Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.

Ostör AG, Duncan A, Quinn M, Rome R.

Gynecol Oncol. 2000 Nov;79(2):207-10.

PMID:
11063645
13.

Cytological follow-up of women older than 50 years with high-grade cervical smear treated by large loop excision.

Das N, Sutton V, Bevan J, Brinkmann D, Woolas R.

J Low Genit Tract Dis. 2009 Jul;13(3):165-8. doi: 10.1097/LGT.0b013e31818eddbc.

PMID:
19550214
14.

Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.

Lea JS, Shin CH, Sheets EE, Coleman RL, Gehrig PA, Duska LR, Miller DS, Schorge JO.

Gynecol Oncol. 2002 Oct;87(1):129-32.

PMID:
12468353
15.

Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.

Miller B, Dunn J, Dalrymple J, Krivak TC.

Gynecol Oncol. 2005 Nov;99(2):489-92. Epub 2005 Jul 28.

PMID:
16054200
16.

Cervical adenocarcinoma in situ: the predictive value of conization margin status.

Young JL, Jazaeri AA, Lachance JA, Stoler MH, Irvin WP, Rice LW, Andersen WA, Modesitt SC.

Am J Obstet Gynecol. 2007 Aug;197(2):195.e1-7; discussion 195.e7-8.

PMID:
17689647
17.

Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.

Krivak TC, Retherford B, Voskuil S, Rose GS, Alagoz T.

Gynecol Oncol. 2000 May;77(2):334-5.

PMID:
10785491
18.

[Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].

Dedecker F, Graesslin O, Bonneau S, Quéreux C.

Gynecol Obstet Fertil. 2008 Jun;36(6):616-22. doi: 10.1016/j.gyobfe.2008.03.010. Epub 2008 Jun 9. French.

PMID:
18539502
19.

Predictive value of diagnoses of endocervical glandular abnormalities in cervical smears.

Segal A, Frost FA, Miranda A, Fletcher C, Sterrett GF.

Pathology. 2003 Jun;35(3):198-203.

PMID:
14506961
Items per page

Supplemental Content

Write to the Help Desk